GEN Exclusives

More »

Automation - Related Content

  • Page 1 of 1 (5 items) 1 
  • New Products

Hudson Robotics

Microbial Picker

The RapidPick Harvester™ is an automated picker for microbial and fungal samples in microplates, omnitrays, and petri dishes. It extracts sample plugs from agar or liquid media. Samples are identified via direct camera image or from output files of

Thermo Fisher Scientific

Autosampler for Organic Volatiles

The TriPlus 300 headspace autosampler has been designed for analyzing organic volatiles. This valve-and-loop headspace autosampler features a 120-vial sample tray capacity and 18-vial incubation oven overlap capacity, enabling unattended high-throu

Hamilton Robotics

ELISA Automation Module

A new module for the Microlab® STAR workstation is available that automates enzyme-linked immunoabsorbant assays (ELISAs). The Microlab ELISA STARlet workstation integrates liquid-handling instrumentation with multiple devices and software. Th

Bio-Rad

Automated Benchtop Cell Sorter

The S3 is a cell-sorting system for core facilities and individual research labs. It is designed to ease bottlenecks by serving as a supplementary instrument for basic cell-sorting work. Equipped with one or two lasers (488 nm and either 561 or 640

BioTek Instruments

Automated Microplate Dispenser

The MultiFlo FX offers up to four independent reagent dispensers and a washer in one platform. Designed to automate microplate-based liquid handling processes, the MultiFlo FX can be used for 6- to 1,536-well plates. It allows a choice of peristalt

  • Page 1 of 1 (5 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?